Market Overview –
The global rat models market was estimate at USD 415.3 MN in 2016, and its value is expect to increase by more than 8.30% over the period 2017–2025. The use of a rat model is widespread in the biomedical, pharmaceutical, and toxicological industries. Outré rats are widely use in toxicity and safety evaluation research, which is anticipate to fuel the market. The expansion of the market is expect to be supporter by the expanding production of innovative medical devices and biotechnology goods.
Technological advances in the rat model sector include microinjections, nuclear transferase, embryonic stem cells, etc. Over the projected timeline, these trends are anticipated to persist. As an example, the growing need for rat models is likely to set the pace for the entire market. The expansion of the market will be fuel by innovations like these in the years to come.
Market Dynamics –
The advantages of rats over mice, steady funding in the form of investments and grants, and rising demand for personalise humanize rat models due to rising consumption of personalise medications are all factors that are propelling the rat model market. However, restrictions on the use of animals in research and the development of technological substitutes for animal models are projects to slow the industry.
Market Scope –
The Rat Model Industry, Forecast to 2028: A Global Sector Trend Analysis is a detail and specialize study on the healthcare market. The purpose of this study is to give readers a synopsis of the rat model market by providing a broad overview as well as a deep segmentation of the market by model type, service, therapeutic area, technology, and end There will be significant development in the Rat model market over the predicate time frame. Key trends and opportunities, as well as data on the market’s current condition, are presenter in the study, which focuses on the rat model industry.
Impacts of the COVID-19 –
Negative effects have been felt by most global industry during the past 18 months. This is because several precautionary lockdowns and other limitations enacts by regulatory bodies around the world caused severe interruptions to their manufacturing and supply-chain activities. In the same way, the international Rat Model industry is not an exception.
It is anticipate that the aforementioned factors will weigh down the revenue growth of the global Rat Model market throughout the foreseen time period.
Market Developments –
MRI&C (The Milner Therapeutics Institute and Consortium) and Charles River Laboratories, Inc. formed a strategic alliance in August of 2016. (UK). Through this collaboration with the Consortium, academic institutions will have access to Charles River’s early discovery and drug development services.
The US-base bioanalytical, drug-metabolism/pharmacokinetic, and pharmacology service provider Agilux Laboratories was acquire by Charles River Laboratories International, Inc. in September 2016. The new building will likely include space for 200 workers engage in production, services, research, and general and administrative tasks.
Research Methodology –
Our research approach combines secondary and primary sources, with the former beginning with extensive data mining and the latter consisting of in-depth interviews with market participants (suppliers, distributors, and end-users) from which we draw conclusions and project future trends.
To evaluate the data across all market categories and competitive landscapes in terms of product satisfaction and business strategy follower to maintain a presence in the market, the report utilize two methodologies: the FPNV Positioning Matrix and the Competitive Strategic Window.
Competitive Landscape –
All of the major companies in the Rat model market are profile in the report, and the report also contains a SWOT analysis and a discussion of their business strategies. Moreover, the research focuses on the top players in the market, providing details such as company profiles, components and services provide, financial information for the past three years, and important developments over the past five years.
Key Companies profiled –
Charles River Laboratories International, Inc.
Horizon Discovery Group plc
Taconic Biosciences, Inc.
Biomedical Research Models (Biomere)
Transpogen Biopharmaceutical, Inc.
By Type –
By Application –
By Region –